Clinical Trial: A Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Pumosetrag in Patients With Gastroesophageal Reflux Disease (GERD)

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional

Official Title: A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Pharmacodynamics of Multiple Dose Levels of Pumosetrag in Patients With Symptoms Associated Wit

Brief Summary: The purpose of this study is to determine if pumosetrag is effective in treating Gastroesophageal Reflux Disease (GERD) symptoms in patients who have a history of GERD symptoms and are currently taking an acid suppression therapy, such as a Proton Pump Inhibitor (PPI).

Detailed Summary:
Sponsor: Edusa Pharmaceuticals, Inc.

Current Primary Outcome:

Original Primary Outcome:

Current Secondary Outcome:

Original Secondary Outcome:

Information By: Edusa Pharmaceuticals, Inc.

Dates:
Date Received: July 12, 2010
Date Started:
Date Completion: May 2011
Last Updated: September 20, 2011
Last Verified: September 2011